VanEck Associates’s IperionX IPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.8M Buy
2,180,089
+842,746
+63% +$35.8M 0.04% 253
2025
Q4
$48.4M Buy
1,337,343
+506,612
+61% +$20.7M 0.04% 249
2025
Q3
$41M Buy
+830,731
New +$33.7M 0.04% 244

Other funds holding IPX

VanEck Associates's IPX Position: Q1 2026 in Review

VanEck Associates increased its IperionX (IPX) stake by 63% in Q1 2026, buying an estimated $35.8M and bringing the position to 2,180,089 shares worth $56.8M. The position accounts for 0.04% of the portfolio, ranked #253.

VanEck Associates first reported a position in IPX in Q3 2025 and has held it in 3 quarters since. 45 funds tracked by Wall St. Rank hold IPX as of Q1 2026.

  • VanEck Associates held 2,180,089 shares of IperionX worth $56.8M as of Q1 2026.
  • VanEck Associates bought 842,746 IperionX shares in Q1 2026, an estimated $35.8M.
  • IperionX made up 0.04% of VanEck Associates's portfolio in Q1 2026, its #253 holding.
  • VanEck Associates first reported a position in IperionX in Q3 2025 and has held it in 3 quarters since.
  • 45 funds tracked by Wall St. Rank held IperionX as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.